Best Integrated Utility Stocks To Watch Right Now

The Company

Seagate Technology (STX) is a company involved in the design, manufacture, marketing and selling of Hard Disk Drives (HDD).

They produce HDDs for enterprise applications (e.g. enterprise servers), client compute applications (mainly for notebooks), and non-compute applications (e.g. portable devices).

Seagate reported latest quarterly results (second-quarter fiscal year 2012) on Jan. 31, 2012, posting an impressive (diluted) EPS of $1.28, compared to an EPS of just $0.31 (around one-fourth) for the second-quarter of last fiscal year.

What is the reason behind such an incredible jump? Someone could think to increased volumes, but in the second quarter of last year Seagate shipped 48.9 million hard disk drives, slightly more than the current number (47 million).

Someone is wondering if the management implemented some form of cost cutting, but if we look at the cost of revenue (keeping in mind that shipment volumes are very simil ar) both quarters show the same number (around $2.2 billions), so this is not the case.

Best Integrated Utility Stocks To Watch Right Now: China GengSheng Minerals Inc. (CHGS)

China GengSheng Minerals, Inc., through its subsidiaries, operates in the materials technology industry. It develops, manufactures, and sells a range of mineral-based, heat-resistant products. The company’s products include refractory products, industrial ceramics, fracture proppants, and fine precision abrasives. Its refractory products comprise castable, coating, and dry mix materials; low-cement and non-cement castables; and pre-cast roofs that are used as linings and key components in industrial furnaces, such as steel production furnaces, ladles, vessels, and other high-temperature processing machines that operate at high temperatures in various industries. The company’s industrial ceramic products consist of abrasive balls and tiles, valves, electronic ceramics, and structural ceramics that are used as components for various end products, such as fuses, vacuum interrupters, electrical components, mud slurry pumps, and high-pressure pumps in the electric power, elec tronic component, industrial pump, and metallurgy industries. Its fracture proppant products include ball-like pellets that are used to reach pockets of oil and natural gas deposits trapped in the fractures under the ground. The company’s fine precision abrasives are primarily used for the surface-polishing and slicing of precision instruments, such as solar panels, as well as in a range of areas, including machinery manufacturing, electronics, optical glass, architecture, industry development, semiconductor, silicon chip, plastic, and lens. China GengSheng Minerals, Inc. sells its products to customers in the iron, steel, oil, glass, cement, aluminum, chemical, and solar industries in China and other parts of Asia, North America, and Europe. The company was formerly known as China Minerals Technologies, Inc. and changed its name to China GengSheng Minerals, Inc. in July 2007. China GengSheng Minerals, Inc. is based in Gongyi, the People’s Republic of China.

Advisors’ Opinion:

  • [By Bryan Murphy]

    If you’re reading this, then odds are you already know that China Gengsheng Minerals Inc. (NYSEMKT:CHGS) shares are up a whopping 60% today. And, odds are good you’re struggling to find a reason why CHGS are running so hard. Here’s some advice – discontinue the hunt. You’re not going to find a reason for all this bullishness in the headlines. Yet, there’s a reason. It’s just a bigger, almost too big to spot kind of reason. Either way, would-be traders can take the hint at face value.

  • [By Bryan Murphy]

    If you’re a small cap enthusiast looking for some budding ideas, you may not need to look any further than China GengSheng Minerals, Inc. (NYSEMKT:CHGS), Bio Matrix Scientific Group Inc. (OTCMKTS:BMSN), and MER Telemanagement Solutions Ltd. (NASDAQ:MTSL). All three have either pushed themselves to the brink of a breakout, if they haven’t started one already. Here’s a closer technical look at MTSL, BMSN, and CHGS, and what it’s going to take to get them going if they’re not going already.

Best Integrated Utility Stocks To Watch Right Now: Taylor Capital Group Inc.(TAYC)

Taylor Capital Group, Inc. operates as the bank holding company for Cole Taylor Bank that provides a range of commercial banking products and services primarily to closely-held commercial customers and their owner operators in the Chicago area. It offers various deposit products, including checking, savings, and money market accounts, as well as time deposits, and other deposit and credit services to commercial clients and community-based customers, including individuals and small local businesses. The company?s commercial lending activities primarily consist of providing loans for working capital and business expansion or acquisition; owner-occupied commercial real estate financing; revolving lines of credit; and stand-by and commercial letters of credit. It also originates and sells mortgage loans. In addition, the company provides treasury cash management services, including repurchase agreements, Internet balance reporting, remote deposit capture, positive pay, automa ted clearing house products, imaged lock-box processing, controlled disbursement, and account reconciliation services to commercial clients; and investment management and brokerage services. Further, it offers asset-based financing, including revolving lines of credit supported by receivables and inventory; and term loans supported by equipment and real estate. The company?s target commercial lending customers include businesses engaged in various industries, such as manufacturing, wholesale and retail distribution, transportation, construction contracting, and professional services. It operates through nine banking centers in the Chicago area. The company was founded in 1929 and is headquartered in Rosemont, Illinois.

Advisors’ Opinion:

  • [By Rich Duprey]

    Commercial banking concern Taylor Capital Group (NASDAQ: TAYC  ) announced yesterday its third-quarter dividend of $0.50 per share on its Series A perpetual non-cumulative preferred stock, which trades on the Nasdaq exchange under the symbol TAYCO.

  • [By Rich Duprey]

    Looking to expand its banking business in the Windy City, MB Financial (NASDAQ: MBFI  ) jointly announced with Taylor Capital (NASDAQ: TAYC  ) that it was buying the holding company of Cole Taylor Bank, a Chicago-based commercial bank with $5.9 billion in assets, $3.3 billion in loans, and $3.7 billion in deposits.

Best Integrated Utility Stocks To Watch Right Now: The Medicines Company(MDCO)

The Medicines Company, a pharmaceutical company, provides various medicines to hospitals for advancing the treatment of critical care patients worldwide. The company markets Angiomax, an intravenous direct thrombin inhibitor for use as an anticoagulant in combination with aspirin in patients with unstable angina undergoing percutaneous transluminal coronary angioplasty and for use in patients undergoing percutaneous coronary intervention; and Cleviprex, an intravenous small molecule calcium channel blocker for the reduction of blood pressure, as well as to treat neurocritical care and cardiac surgery patients. Its products under development include Cangrelor that is in Phase III clinical trial acts as an intravenous small molecule antiplatelet agent to prevent platelet activation and aggregation; and Oritavancin, which is in Phase III clinical trial acts as an investigational intravenous antibiotic for the treatment of serious gram-positive bacterial infections, including acute bacterial skin and skin structure infections. The company?s products under development also comprise MDCO-157, a pre-registration stage product for platelet inhibition in patients suffering from acute coronary syndrome (ACS), and patients experiencing myocardial infarction, stroke, or peripheral arterial disease; MDCO-2010, a small molecule serine protease inhibitor that is in Phase II clinical trial used for the reduction of blood loss during surgery; and MDCO-216, which is in Phase I clinical trial used for the reversal of atherosclerotic plaque development and the reduction of the risk of coronary events in patients with ACS. Its products also consist of Argatroban, a direct thrombin inhibitor used as anticoagulant for prophylaxis or for the treatment of thrombosis; and acute care generic products. The Medicines Company was founded in 1996 and is based in Parsippany, New Jersey.

Advisors’ Opinion:

  • [By Jake L’Ecuyer]

    Equities Trading DOWN
    Shares of The Medicines Company (NASDAQ: MDCO) were down 14.64 percent to $24.26 after the company provided an update on Angiomax patent litigation.

  • [By Lisa Levin]

    The Medicines Company (NASDAQ: MDCO) shares touched a new 52-week low of $24.17 after the company provided an update on Angiomax patent litigation.

Best Integrated Utility Stocks To Watch Right Now: Stanley Furniture Company Inc.(STLY)

Stanley Furniture Company, Inc., together with its subsidiaries, designs, manufactures, and imports wood furniture products for the residential market. It offers a line of adult furniture products comprising dining, bedroom, home office, home entertainment, and accent items under the Stanley Furniture brand name; and children?s furniture product line under the brand name of Young America. The company provides its products under various design categories, including traditional, continental, contemporary, transitional, and cottage designs. Stanley Furniture Company, Inc. sells its furniture products through independent sales representatives to independent furniture stores, interior designers, smaller specialty retailers, regional furniture chains, buying clubs, and e-tailers in the United States. Stanley Furniture Company, Inc. was founded in 1924 and is based in High Point, North Carolina.

Advisors’ Opinion:

  • [By Anna Prior]

    Stanley Furniture Co.(STLY) said it will close a North Carolina factory that manufactures its Young America brand, shifting operations to its growing Stanley line. The move will delay the company’s first-quarter report until after the market closes on April 30 as the company evaluates restructuring charges. Shares dropped 4.8% to $2.60 premarket.

  • [By Monica Gerson]

    Stanley Furniture Co (NASDAQ: STLY) is estimated to post a Q3 loss at $0.11 per share on revenue of $25.32 million.

    Posted-In: Earnings scheduleEarnings News Pre-Market Outlook Markets

Best Integrated Utility Stocks To Watch Right Now: AstraZeneca PLC (AZN)

AstraZeneca PLC (AstraZeneca), incorporated on June 17, 1992, is a global biopharmaceutical company. AstraZeneca discovers, develops and commercializes prescription medicines for six areas of healthcare: Cardiovascular, Gastrointestinal, Infection, Neuroscience, Oncology, and Respiratory and Inflammation. It has a range of medicines that includes treatments for illnesses, such as its antibiotic, Merrem/Meronem and Losec/Prilosec for acid related diseases. AstraZeneca’s products include Crestor, Atacand,Seloken/Toprol-XL, Plendil, Onglyza, Zestril, Symbicort and Zoladex. The Company owns and operates a range of research and development (R&D), production and marketing facilities worldwide. AstraZeneca operates in over 100 countries, including China, Mexico, Brazil and Russia. On August 31, 2011, the Company completed the sale of the Astra Tech business to DENTSPLY International Inc. On June 19, 2012, the Company acquired Ardea Biosciences Inc (Ardea), a biotechnology compa ny in San Diego, California. In July 2012, the Company acquired a portfolio of neuroscience assets from Link Medicine Corporation. In August 2012, Alliance Pharma plc’s wholly owned subsidiary, Alliance Pharmaceuticals Limited, acquired the antimalarial brands Paludrine, Avloclor and Savarine from AstraZeneca UK Limited. In August 2012, the Company and Bristol-Myers Squibb Company announced the acquisition of Amylin Pharmaceuticals, Inc. by Bristol-Myers Squibb Company. In June 2013, the Company acquired Pearl Therapeutics.

Cardiovascular

The Company’s marketed products include Crestor (rosuvastatin calcium), Atacand2 (candesartan cilexetil), Seloken/Toprol-XL (metoprolol succinate), Tenormin (atenolol), Plendil (felodipine), Zestril3 (lisinopril dihydrate), Brilinta/Brilique (ticagrelor), and Axanum, (acetylsalicylic acid (ASA). Crestor1 is a statin used for the treatment of dyslipidaemia and hypercholesterolemia. In some markets, it is also in dicated to slow the progression of atherosclerosis and to re! duce the risk of first cardiovascular (CV) events. Atacand2 is an angiotensin II antagonist used for the 1st line treatment of hypertension and symptomatic heart failure. Seloken/Toprol-XL is a beta-blocker once-daily tablet used for 24-hour control of hypertension and for use in heart failure and angina.

Tenormin is a cardioselective beta-blocker used for hypertension, angina pectoris and other CV disorders. Plendil is a calcium antagonist used for the treatment of hypertension and angina. Zestril3 is an angiotensin-converting enzyme inhibitor used for the treatment of a wide range of CV diseases, including hypertension. Brilinta/Brilique is an oral antiplatelet for the treatment of acute coronary syndromes (ACS). Axanum is a fixed dose combination indicated for prevention of CV events in high-risk CV patients in need of daily low-dose ASA treatment and who are at risk of gastric ulcers.

The Company’s marketed products for diabetes include Kombog lyze ((saxagliptin and metformin HCl), Kombiglyze XR (saxagliptin and metformin XR) and Onglyza (saxagliptin). Komboglyze is an immediate release fixed dose combination indicated as an adjunct to diet and exercise to improve glycaemic control in adult patients with Type 2 diabetes mellitus inadequately controlled on their maximally tolerated dose of metformin alone or those already being treated with the combination of saxagliptin and metformin as separate tablets. Kombiglyze XR is an extended release fixed dose combination indicated as an adjunct to diet and exercise to improve glycaemic control in adults with Type 2 diabetes mellitus when treatment with both saxagliptin and metformin is appropriate. Onglyza is a DPP-IV inhibitor used for the treatment of Type 2 diabetes.

Gastrointestinal

AstraZeneca’s marketed products include Nexium (esomeprazole), Losec/Prilosec (omeprazole) and Entocort (budesonide). Nexium is a proton pump inhibitor (PPI) us ed for the treatment of acid-related diseases to offer clini! cal impro! vements over other PPIs and other treatments. Losec/Prilosec is used for the short-term and long-term treatment of acid-related diseases. Entocort is a corticosteroid used for the treatment of inflammatory bowel disease. Nexium is marketed in approximately 120 countries and is available in oral (tablet/capsules and oral suspension) and intravenous (i.v.) dosage forms for the treatment of acid-related diseases.

Infection

The Company’s marketed products include Merrem/Meronem (meropenem), Cubicin (daptomycin) and FluMist/Fluenz (influenza vaccine live, intranasal). Merrem/Meronem is a carbapenem anti-bacterial used for the treatment of serious infections in hospitalised patients. Cubicin is a cyclic lipopeptide anti-bacterial used for the treatment of serious infections in hospitalised patients. FluMist/Fluenz is an intranasal live, attenuated, trivalent influenza vaccine.

Neuroscience

AstraZeneca’s marketed products inc lude Seroquel IR (quetiapine fumarate), Seroquel XR (an extended release formulation of quetiapine fumarate), Zomig (zolmitriptan), Diprivan (propofol), Vimovo (naproxen/esomeprazole magnesium), Naropin (ropivacaine), Xylocaine (lidocaine) and EMLA (lidocaine and prilocaine). Seroquel IR is an atypical anti-psychotic drug used for the treatment of schizophrenia and bipolar disorder (mania, depression and maintenance). Seroquel XR is used for the treatment of schizophrenia, bipolar disorder, MDD and in some territories for generalised anxiety disorder (GAD).

Zomig is used for the treatment of migraines with or without aura and Zomig Nasal Spray is indicated for the acute treatment of cluster. Diprivan is an intravenous general anaesthetic used in the induction and maintenance of general anaesthesia, for use in intensive care sedation and conscious sedation for surgical as well as diagnostic procedures. Vimovo is a fixed-dose combination of enteric-coated naproxe n (an NSAID) with the gastroprotection of immediate release ! esomepraz! ole (a proton pump inhibitor) for the relief of signs and symptoms of osteoarthritis, rheumatoid arthritis and ankylosing spondylitis, and to decrease the developing of gastric ulcers in patients at risk of developing NSAID-associated gastric ulcers. Naropin is used as a long-acting local anaesthetic, for surgical anaesthesia and acute pain management. Xylocaine is a used short-acting local anaesthetic. EMLA is used as a local anaesthetic for topical application.

Oncology

AstraZeneca’s marketed products include Arimidex (anastrozole), Zoladex (goserelin acetate implant), Casodex (bicalutamide), Iressa (gefitinib), Faslodex (fulvestrant), Nolvadex (tamoxifen citrate) and Caprelsa (vandetanib). Arimidex is an aromatase inhibitor used for the treatment of early breast cancer. Zoladex, in one- and three-month depots, is a luteinising hormone-releasing hormone agonist used for the treatment of prostate cancer, breast cancer and certain benign gynaecol ogical disorders. Casodex is an anti-androgen therapy used for the treatment of prostate cancer.

Advisors’ Opinion:

  • [By Jayson Derrick]

    AstraZeneca (NYSE: AZN) said that its Nexium therapy is safe despite an FDA-imposed ban on US shipments on a key ingredient’s manufacturer. Shares gained 0.15 percent, closing at $66.94.

  • [By Peter Stephens]

    GlaxoSmithKline isn’t the only pharmaceutical company that’s had some encouraging news flow with regard to its drug pipeline in 2014. The diabetes alliance between Bristol-Myers Squibb (NYSE: BMY  ) and AstraZeneca (NYSE: AZN  ) , which has now been bought outright by AstraZeneca for around $4 billion, has received approval for two drugs in 2014: Farxiga in the U.S. and combination drug Xigduo in the European Union.

Best Integrated Utility Stocks To Watch Right Now: WhiteWave Foods Co (WWAV)

WWF Operating Company, incorporated on March 14, 1988, is a consumer packaged food and beverage company. The Company manufactures, markets, distributes, and sells plant-based foods and beverages, coffee creamers and beverages, and dairy products throughout North America and Europe. The Company operates in two segments: North America and Europe. The North America segment offers products in the plant-based foods and beverages, coffee creamers and beverages, and dairy product categories throughout North America. Europe segment offers plant-based food and beverage products throughout Europe. The Company is a wholly owned subsidiary of Dean Foods Company (Dean Foods).

The Company’s brands distributed in North America include Silk plant-based foods and beverages, International Delight and LAND O LAKES coffee creamers and beverages, and Horizon Organic dairy products, while its European brands of plant-based foods and beverages include Alpro and Provamel. The Compa ny sell its products to a variety of customers, including grocery stores, mass merchandisers, club stores, and convenience stores, as well as various away-from-home channels, including restaurants and foodservice outlets, across North America and Europe. The Company sells its products in North America and Europe primarily through its direct sales force and independent brokers. The Company utilizes five manufacturing plants, two distribution centers, and three co-packers across the United States. Additionally, it has four plants across Europe in the United Kingdom, Belgium, France, and the Netherlands, each supported by an integrated supply chain.

Advisors’ Opinion:

  • [By Pendulum]

    Organic / Health Foods companies:

    Hain Celestial (HAIN)WhiteWave (WWAV)Annie’s

    Best In Class Food Companies:

    Coca-Cola (KO)Pepsico (PEP)Mondelez (MDLZ)Kraft Foods (KRFT)General Mills (GIS)Kellogg (K)ConAgra Foods (CAG)Hershey (HSY)J.M. Smucker (SJM)McCormick (MKC)Dean Foods (DF)

    A few comments about this analysis:

  • [By Rich Duprey]

    WhiteWave Foods (NYSE: WWAV  ) , the Dean Foods spinoff whose organic products go out of their way to certify that they avoid being tainted with GMO ingredients, still sells Land o’ Lakes products that contain sucralose.

  • [By Michael Lewis]

    Dairy pure-play Dean Foods (NYSE: DF  ) is flirting with its 52-week high after an encouraging earnings report released earlier this week. As it so often goes in special situations, investors deemed the company relatively uninteresting after a high profile spin-off of plant-based food segment WhiteWave (NYSE: WWAV  ) and divestiture of Morningstar — purveyor of staples such as International Creamer. Skeptics cited declining milk consumption and heavy debt as detractors to the stock, but, post spin-off, Dean Foods is a cash-generating, inexpensive pick in an otherwise difficult sector. With the recent earnings report in mind, let’s take a closer look.

  • [By John Maxfield]

    Meanwhile, the worst-performing stock on the index was Dean Foods (NYSE: DF  ) , which lost more than half of its value. This otherwise disturbing performance followed the company’s spinoff of its organic-foods division, WhiteWave Foods (NYSE: WWAV  ) . As fellow Fool Rich Duprey covered here, each Dean Foods shareholder received 0.25544448 shares of WhiteWave class A stock and 0.36380189 shares of its class B stock for every share of Dean Foods.